Abstract |
[(11)C] Dimebon (2-[(11)C]methyl-8-methyl-5-(2-(6-methylpyridin-3-yl)ethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b] indole), a new potential PET agent for imaging of Alzheimer's disease and Huntington's disease, was prepared by N-[(11)C]methylation of desmethyl-Domebon precursor with [(11)C]CH(3)OTf and purified with a semi-preparative HPLC method in 30-40% decay corrected radiochemical yield and 222-296GBq/mumol specific activity at EOB. The measured lipophilicity coefficient (LogP) value of [(11)C] Dimebon was 2.53.
|
Authors | Mingzhang Gao, Min Wang, Gary D Hutchins, Qi-Huang Zheng |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 20
Issue 8
Pg. 2529-32
(Apr 15 2010)
ISSN: 1464-3405 [Electronic] England |
PMID | 20299213
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Copyright 2010 Elsevier Ltd. All rights reserved. |
Chemical References |
- Carbon Radioisotopes
- Indoles
- latrepirdine
|
Topics |
- Alzheimer Disease
(diagnostic imaging)
- Carbon Radioisotopes
- Chromatography, High Pressure Liquid
- Humans
- Huntington Disease
(diagnostic imaging)
- Indoles
(chemical synthesis, pharmacology)
- Positron-Emission Tomography
|